Letter to the editor regarding systematic review and meta-analysis of the efficacy of gabapentin in chronic female pelvic pain without another diagnosis
This letter to the editor discusses the systematic review and meta-analysis of gabapentin's efficacy in treating chronic female pelvic pain when no other specific diagnosis is present.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (6)
- Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial via openalex
- Gabapentin for the management of chronic pelvic pain in women via openalex
- Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial via openalex
- Systematic review and meta-analysis of the efficacy of gabapentin in chronic female pelvic pain without another diagnosis via openalex
- The use of brain functional magnetic resonance imaging to determine the mechanism of action of gabapentin in managing chronic pelvic pain in women: a pilot study via openalex
- W6805445989 via openalex
Source provenance
- europepmc
- last seen: 2026-08-30T09:23:35.175841+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00